Evidence map›Paper›PMID 38932284›Full record

ArticleViruses2024

Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection.

Maria Grazia Crobu, Paolo Ravanini, Clotilde Impaloni, Claudia Martello, Olivia Bargiacchi, Christian Di Domenico, Giulia Faolotto, Paola Macaluso, Alessio Mercandino, Miriam Riggi and 4 more

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Maria Grazia CrobuLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.
Paolo RavaniniLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.
Clotilde ImpaloniLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.ORCID 0009-0008-7694-0740
Claudia MartelloLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.
Olivia BargiacchiUnit of Infectious Diseases, Maggiore della Carità Hospital, 28100 Novara, Italy.
Christian Di DomenicoLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.
Giulia FaolottoLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.ORCID 0000-0003-4558-3230
Paola MacalusoLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.
Alessio MercandinoLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.
Miriam RiggiLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.
Vittorio QuagliaLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.
Stefano AndreoniLaboratory of Molecular Virology, Maggiore della Carità Hospital, 28100 Novara, Italy.
Mario PirisiInternal Medicine Unit, Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
Carlo SmirneInternal Medicine Unit, Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0002-3338-5416

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies reported that the hepatitis C virus (HCV) could help disseminate the hepatitis D virus (HDV) in vivo through hepatitis B virus (HBV)-unrelated ways, but with essentially inconclusive results. To try to shed light on this still-debated topic, 146 anti-HCV-positive subjects (of whom 91 HCV/HIV co-infected, and 43 with prior HCV eradication) were screened for anti-HDV antibodies (anti-HD), after careful selection for negativity to any serologic or virologic marker of current or past HBV infection. One single HCV/HIV co-infected patient (0.7%) tested highly positive for anti-HD, but with no positive HDV-RNA. Her husband, in turn, was a HCV/HIV co-infected subject with a previous contact with HBV. While conducting a thorough review of the relevant literature, the authors attempted to exhaustively describe the medical history of both the anti-HD-positive patient and her partner, believing it to be the key to dissecting the possible complex mechanisms of HDV transmission from one subject to another, and speculating that in the present case, it may have been HCV itself that behaved as an HDV helper virus. In conclusion, this preliminary research, while needing further validation in large prospective studies, provided some further evidence of a role of HCV in HDV dissemination in humans.

Indexed as

CoinfectionHepacivirusHepatitis CHepatitis DHepatitis Delta VirusHelper VirusesHepatitis AntibodiesHepatitis BHIV InfectionsHumansRNA, ViralHepatitis AntibodiesRNA, Viralanti-HBcco-infectionHDV-RNAhelper virushepatitis B virushepatitis C virushepatitis D virushuman immunodeficiency viruspropagationsuperinfection

Identifiers

PMID38932284
PMCPMC11209499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.